| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.373 | 10.958 | 22.727 | 18.292 | 37.439 | 54.503 |
| Total Income - EUR | - | - | - | - | 4.373 | 10.958 | 22.727 | 18.292 | 37.439 | 54.503 |
| Total Expenses - EUR | - | - | - | - | 1.173 | 7.191 | 20.697 | 14.070 | 32.534 | 50.667 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.200 | 3.767 | 2.030 | 4.221 | 4.904 | 3.836 |
| Net Profit/Loss - EUR | - | - | - | - | 3.069 | 3.447 | 1.424 | 3.749 | 4.237 | 3.456 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Endomax Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 51 | 5.650 | 4.818 | 4.124 | 9.191 | 13.092 |
| Current Assets | - | - | - | - | 3.113 | 4.503 | 4.114 | 8.219 | 8.259 | 16.121 |
| Inventories | - | - | - | - | 0 | 25 | 0 | 55 | 2.092 | 11.196 |
| Receivables | - | - | - | - | 0 | 4.045 | 3.969 | 6.158 | 635 | 1.023 |
| Cash | - | - | - | - | 3.113 | 433 | 145 | 2.006 | 5.532 | 3.903 |
| Shareholders Funds | - | - | - | - | 3.111 | 6.499 | 7.779 | 11.553 | 15.755 | 19.123 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 53 | 3.654 | 1.152 | 790 | 1.695 | 10.090 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Endomax Med S.r.l.